| 6,136 | 199 | 2037 |
| 下载次数 | 被引频次 | 阅读次数 |
<正>慢性前列腺炎/慢性盆腔疼痛综合征(chronic prostatitis/chronic pelvic pain syndrome, CP/CPPS)是泌尿男科常见疾病,对患者身心健康造成不良影响,并严重影响其生活质量。CP/CPPS发病机制复杂多样,治疗方案繁杂,且疗效不确定,给临床工作带来极大困扰。近年来该领域进展很快,为了规范诊疗方案,更好地指导临床实践,在查阅了最新研究成果,并参考了国内外相关指南和专家共识的基础上,
Abstract:[1] Krieger J,Nyberg L J,Nickel J.NIH consensus definition and classification of prostatitis.JAMA,1999,282(3):236-237.
[2] Nickel JC,Alexander RB,Schaeffer AJ,et al.Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls.J Urol,2003,170(3):818-822.
[3] Nickel JC,Freedland SJ,Castro-Santamaria R,et al.Chronic prostate inflammation predicts symptom progression in patients with chronic prostatitis/chronic pelvic pain.J Urol,2017,198(1):122-128.
[4] Dagher A,Curatolo A,Sachdev M,et al.Identification of novel non-invasive biomarkers of urinary chronic pelvic pain syndrome:Findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.BJU Int,2017,120(1):130-142.
[5] Shoskes DA,Nickel JC,Rackley RR,et al.Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis:A management strategy for urologic chronic pelvic pain syndromes.Prostate Cancer Prostatic Dis,2009,12(2):177-183.
[6] Davis SN,Binik YM,Amsel R,et al.Is a sexual dysfunction domain important for quality of life in men with urological chronic pelvic pain syndrome?Signs "UPOINT" to yes.J Urol,2013,189(1):146-151.
[7] Samplaski MK,Li J,Shoskes DA.Inclusion of erectile domain to UPOINT phenotype does not improve correlation with symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome.Urology,2011,78(3):653-658.
[8] 梁朝朝,樊松.将Ⅲ型前列腺炎更名为前列腺盆腔综合征的提出与思考.中华泌尿外科杂志,2020,41(5):326-329.
[9] Rizzo M,Marchetti F,Travaglini F,et al.Prevalence,diagnosis and treatment of prostatitis in Italy:A prospective urology outpatient practice study.BJU Int,2003,92(9):955-959.
[10] 梁朝朝.加强我国慢性前列腺炎的流行病学研究.中华泌尿外科杂志,2006,27(8):509-511.
[11] Krieger NJ,Lee SW,Jeon J,et al.Epidemiology of prostatitis.Int J Antimicrob Agents,2008,31(Suppl 1):S85-S90.
[12] Liang CZ,Zhang XJ,Hao ZY,et al.An epidemiological study of patients with chronic prostatitis.BJU Int,2004,94(4):568-570.
[13] 米华,陈凯,莫曾南.中国慢性前列腺炎的流行病学特征.中华男科学杂志,2012,18(7):579-582.
[14] 贺利军,王义,周哲,等.北京市石景山区1006例男性泌尿生殖健康调查.中华男科学杂志,2012,18(4):356-358.
[15] Shin JH,Lee G.Seasonal changes in symptoms in patients with chronic prostatitis/chronic pelvic pain syndrome:A seasonal follow-up study.Scand J Urol,2014,48(6):533-537.
[16] Herati AS,Shorter B,Srinivasan AK,et al.Effects of foods and beverages on the symptoms of chronic prostatitis/chronic pelvic pain syndrome.Urology,2013,82(6):1376-1380.
[17] Liang CZ,Li HJ,Wang ZP,et al.The prevalence of prostatitis-like symptoms in China.J Urol,2009,182(2):558-563.
[18] Gallo L.Effectiveness of diet,sexual habits and lifestyle modifications on treatment of chronic pelvic pain syndrome.Prostate Cancer Prostatic Dis,2014,17(3):238-245.
[19] 梁宏,邓春华,李伟明,等.尿道前列腺返流显像及其在慢性前列腺炎的应用.中华核医学杂志,1999,19(2):34-35.
[20] Mandar R,Korrovits P,Rahu K,et al.Dramatically deteriorated quality of life in men with prostatitis-like symptoms.Andrology,2020,8(1):101-109.
[21] Pontari MA,Mcnaughton-Collins M,O'Leary MP,et al.A case-control study of risk factors in men with chronic pelvic pain syndrome.BJU Int,2005,96(4):559-565.
[22] Forrest JB,Schmidt S.Interstitial cystitis,chronic nonbacterial prostatitis and chronic pelvic pain syndrome in men:A common and frequently identical clinical entity.J Urol,2004,172(4):2561-2562.
[23] Choi JB,Lee SJ,Kang SR,et al.Analysis of bacterial community using pyrosequencing in semen from patients with chronic pelvic pain syndrome:A pilot study.Transl Androl Urol,2020,9(2):398-404.
[24] Wu Y,Jiang H,Tan M,et al.Screening for chronic prostatitis pathogens using high-throughput next-generation sequencing.Prostate,2020,80(7):577-587.
[25] Hochreiter WW,Z'Brun S.Chronic pelvic pain syndrome and voiding dysfunction.Curr Urol Rep,2004,5(4):300-304.
[26] Persson BE,Ronquist G.Evidence for a mechanistic association between nonbacterial prostatitis and levels of urate and creatinine in expressed prostatic secretion.J Urol,1996,155(3):958-960.
[27] Parsons CL.Prostatitis,interstitial cystitis,chronic pelvic pain,and urethral syndrome share a common pathophysiology:Lower urinary dysfunctional epithelium and potassium recycling.Urology,2003,62(6):976-982.
[28] Liang CZ,Guo QK,Hao ZY,et al.K+ channel expression in prostate epithelium and its implications in men with chronic prostatitis.BJU Int,2006,97(1):190-192.
[29] Yilmaz U,Liu YW,Berger RE,et al.Autonomic nervous system changes in men with chronic pelvic pain syndrome.J Urol,2007,177(6):2170-2174.
[30] Kutch JJ,Yani MS,Asavasopon S,et al.Altered resting state neuromotor connectivity in men with chronic prostatitis/chronic pelvic pain syndrome:A MAPP:Research Network Neuroimaging Study.Neuroimage Clin,2015,8:493-502.
[31] Shahed AR,Shoskes DA.Correlation of beta-endorphin and prostaglandin E2 levels in prostatic fluid of patients with chronic prostatitis with diagnosis and treatment response.J Urol,2001,166(5):1738-1741.
[32] 张凯,贺利军,虞巍,等.22~50岁中国人精神心理健康状况与下尿路症状及阴茎勃起功能障碍的相关性(英文).北京大学学报(医学版),2013,45(4):609-612.
[33] Zhang GX,Bai WJ,Xu T,et al.A preliminary evaluation of the psychometric profiles in Chinese men with chronic prostatitis/chronic pelvic pain syndrome.Chin Med J (Engl),2011,124(4):514-518.
[34] Giannantoni A,Porena M,Gubbiotti A,et al.The efficacy and safety of duloxetine in a multidrug regimen for chronic prostatitis/chronic pelvic pain syndrome.Urology,2014,83(2):400-405.
[35] Pavone C,Caldarera E,Liberti P,et al.Correlation between chronic prostatitis syndrome and pelvic venous disease:A survey of 2,554 urologic outpatients.Eur Urol,2000,37(4):400-403.
[36] Zhang M,Liu Y,Chen J,et al.Single-cell multi-omics analysis presents the landscape of peripheral blood T-cell subsets in human chronic prostatitis/chronic pelvic pain syndrome.J Cell Mol Med,2020,24(23):14099-14109.
[37] Hua X,Ge S,Zhang M,et al.Pathogenic roles of CXCL10 in experimental autoimmune prostatitis by modulating macrophage chemotaxis and cytokine secretion.Front Immunol,2021,12:706027.
[38] 张敏建,陈康,翟芳同,等.慢性前列腺炎患者前列腺液活性氧表达变化及意义.中华泌尿外科杂志,2006,27(8):516-519.
[39] Riley DE,Krieger JN.X Chromosomal short tandem repeat polymorphisms near the phosphoglycerate kinase gene in men with chronic prostatitis.Biochim Biophys Acta,2002,1586(1):99-107.
[40] Zaidi N,Thomas D,Chughtai B.Management of chronic prostatitis (CP).Curr Urol Rep,2018,19(11):88.
[41] Rees J,Abrahams M,Doble A,et al.Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome:A consensus guideline.BJU Int,2015,116(4):509-525.
[42] Magistro G,Wagenlehner FM,Grabe M,et al.Contemporary management of chronic prostatitis/chronic pelvic pain syndrome.Eur Urol,2016,69(2):286-297.
[43] 樊松,刘祎,虞勤舟,等.慢性前列腺炎/慢性盆腔疼痛综合征患者抑郁症状的危险因素分析及预测模型构建.中国男科学杂志,2020,34(4):7-12.
[44] Shoskes DA,Nickel JC.Classification and treatment of men with chronic prostatitis/chronic pelvic pain syndrome using the UPOINT system.World J Urol,2013,31(4):755-760.
[45] Litwin MS.A review of the development and validation of the national institutes of health chronic prostatitis symptom index.Urology,2002,60(6 suppl):14-18.
[46] Rosen RC,Cappelleri JC,Smith MD,et al.Development and evaluation of an abridged,5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction.Int J Impot Res,1999,11(6):319-326.
[47] Symonds T,Perelman MA,Althof S,et al.Development and validation of a premature ejaculation diagnostic tool.Eur Urol,2007,52(2):565-573.
[48] Hikita KS,Honda M,Hirano S,et al.Comparison of the overactive bladder symptom score and the overactive bladder symptom score derived from the bladder diaries.Neurourol Urodyn,2016,35(3):349-353.
[49] Shy M,Fletcher SG.Objective evaluation of overactive bladder:Which surveys should I use?Curr Bladder Dysfunct Rep,2013,8(1):45-50.
[50] 张杰,潘永军,黄捷,等.经皮胫神经电刺激联合心理干预治疗难治性CP/CPPS的临床研究.中国男科学杂志,2018,32(4):21-24.
[51] 俞柳韵,富晶晶,杨艳.自我管理干预对改善慢性前列腺炎患者生活质量的效果评价.中国男科学杂志,2020,34(4):57-61.
[52] Li X,Jiang T,Liu F,et al.Clinical evaluation of urine prostatic exosomal protein in the diagnosis of chronic prostatitis.Urol Int,2018,100(1):112-118.
[53] 闫泽晨,李凯强,李奕泽,等.前列腺小体外泄蛋白与EPS常规指标和NIH-CPSI的相关性分析.中华男科学杂志,2019,25(6):500-503.
[54] Liang W,Wu Z,Zhang G,et al.A urine-based biomarker for chronic prostatitis/chronic pelvic pain syndrome:A retrospective multi-center study.Transl Androl Urol,2020,9(5):2218-2226.
[55] 世界卫生组织.人类精液检查与处理实验室手册(第5版).北京:人民卫生出版社,2011.110.
[56] Weidner W,Anderson RU.Evaluation of acute and chronic bacterial prostatitis and diagnostic management of chronic prostatitis/chronic pelvic pain syndrome with special reference to infection/inflammation.Int J Antimicrob Agents,2008,31S(1):S91-S95.
[57] Nickel JC,Shoskes D,Wang Y,et al.How does the pre-massage and post-massage 2-glass test compare to the meares-stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome.J Urol,2006,176(1):119-124.
[58] Motrich RD,Salazar FC,Breser ML,et al.Implications of prostate inflammation on male fertility.Andrologia,2018,50(11):e13093.
[59] Nickel JC.Classification and diagnosis of prostatitis:A gold standard?Andrologia,2003,35(3):160-167.
[60] Ludwig M,Weidner W,Schroeder-Printzen I,et al.Transrectal prostatic sonography as a useful diagnostic means for patients with chronic prostatitis or prostatodynia.Br J Urol,1994,73(6):664-668.
[61] Ioannis G,Kostis G,Petros P,et al.Clinical correlation of prostatic lithiasis with chronic pelvic pain syndromes in young adults.Eur Urol,2004,45(3):333-338.
[62] Suskind AM,Berry SH,Ewing BA,et al.The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men:Results of the RAND Interstitial Cystitis Epidemiology Male Study.J Urol,2013,189(1):141-145.
[63] Takizawa N,Matsuzaki T,Yamamoto T,et al.Novel strategy for cystitis glandularis:Oral treatment with cyclooxygenase-2 inhibitor.Int J Urol,2016,23(8):706-708.
[64] Park SH,Ryu JK,Choo GY,et al.Chronic bacterial seminal vesiculitis as a potential disease entity in men with chronic prostatitis.Int J Urol,2015,22(5):508-512.
[65] Calixte N,Brahmbhatt J,Parekattil S.Chronic testicular and groin pain:Pathway to relief.Curr Urol Rep,2017,18(10):83.
[66] Shoskes DA,Wang H,Polackwich AS,et al.Analysis of gut microbiome reveals significant differences between men with chronic prostatitis/chronic pelvic pain syndrome and controls.J Urol,2016,196(2):435-441.
[67] Vicari E,La Vignera S,Castiglione R,et al.Chronic bacterial prostatitis and irritable bowel syndrome:Effectiveness of treatment with rifaximin followed by the probiotic VSL#3.Asian J Androl,2014,16(5):735-739.
[68] Hu J,Zhang L,Zou L,et al.Role of inflammation in benign prostatic hyperplasia development among Han Chinese:A population-based and single-institutional analysis.Int J Urol,2015,22(12):1138-1142.
[69] 张祥华,王行环,王刚,等.良性前列腺增生临床诊治指南.中华外科杂志,2007,45(24):1704-1707.
[70] 曾宪涛,李胜,龚侃,等.良性前列腺增生症临床诊治实践指南的循证评价.中华医学杂志,2017,97(22):1683-1687.
[71] He W,Chen M,Zu X,et al.Chronic prostatitis presenting with dysfunctional voiding and effects of pelvic floor biofeedback treatment.BJU Int,2010,105(7):975-977.
[72] Horner PJ,Blee K,Falk L,et al.2016 European guideline on the management of non-gonococcal urethritis.Int J STD AIDS,2016,27(11):928-937.
[73] Pape? D,Pasini M,Jeroncic A,et al.Detection of sexually transmitted pathogens in patients with chronic prostatitis/chronic pelvic pain:A prospective clinical study.Int J STD AIDS,2017,28(6):613-615.
[74] Xiao J,Ren L,Lv H,et al.Atypical microorganisms in expressed prostatic secretion from patients with chronic prostatitis/chronic pelvic pain syndrome:Microbiological results from a case-control study.Urol Int,2013,91(4):410-416.
[75] Babjuk M,Burger M,Comperat EM,et al.European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.EurUrol,2019,76(5):639-657.
[76] Zhao WP,Li YT,Chen J,et al.Prostatic calculi influence the antimicrobial efficacy in men with chronic bacterial prostatitis.Asian J Androl,2012,14(5):715-719.
[77] 朱肖峰,姚吉,汤忠木,等.输尿管下段结石误诊前列腺炎12例分析.2006年浙江省泌尿外科学术会议论文汇编.2006.193-194.
[78] 谢胜,张少峰,贾洪涛,等.后尿道结石误诊为前列腺炎2例分析.中国误诊学杂志,2007,7(6):1270.
[79] Polackwich AS,Shoskes DA.Chronic prostatitis/chronic pelvic pain syndrome:A review of evaluation and therapy.Prostate Cancer and Prostatic Diseases,2016,19(2):132-138.
[80] 俞旭君,高庆和.慢性前列腺炎中西医结合多学科诊疗指南.中华男科学杂志,2020,26(4):369-376.
[81] Appiya SM,Ullah Khan F,Naveed M,et al.Interventions to chronic prostatitis/Chronic pelvic pain syndrome treatment.Where are we standing and what's next?Eur J Pharmacol,2019,857:172429.
[82] Herati A,Moldwin R.Alternative therapies in the management of chronic prostatitis/chronic pelvic pain syndrome.World J Urol,2013,31(4):761-766.
[83] Chen X,Hu C,Peng Y,et al.Association of diet and lifestyle with chronic prostatitis/chronic pelvic pain syndrome and pain severity:A case-control study.Prostate Cancer Prostatic Dis,2016,19(1):92-99.
[84] Tripp D.Managing psychosocial correlates of urologic chronic pelvic pain syndromes:Advice from a urology pain psychologist.Can Urol Assoc J,2018,12(6 Suppl 3):S157-S175.
[85] Zhang R,Chomistek AK,Dimitrakoff JD,et al.Physical activity and chronic prostatitis/chronic pelvic pain syndrome.Med Sci Sports Exerc,2015,47(4):757-764.
[86] Franco J,Turk T,Jung JH,et al.Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.Cochrane Database Syst Rev,2018,5(5):D12551.
[87] 张勇,孙凤岭,臧桐.药物联合局部热疗治疗慢性前列腺炎疼痛症状的疗效(附76例报告).中华男科学杂志,2008,14(5):451-453.
[88] 吴隽,胡向农,杨建军.生物反馈电刺激疗法联合前列腺按摩治疗慢性前列腺炎/慢性骨盆疼痛综合征的临床疗效观察.中华男科学杂志,2020,26(11):996-999.
[89] 刘骋,梁朝朝,郝宗耀,等.慢性前列腺炎病原学初步研究.中华泌尿外科杂志,2005,26(12):826-828.
[90] Perletti G,Marras E,Wagenlehner FME,et al.Antimicrobial therapy for chronic bacterial prostatitis.Cochrane Database Syst Rev,2013,12(8):9-71.
[91] Cai T,Mazzoli S,Addonisio P,et al.Clinical and microbiological efficacy of prulifloxacin for the treatment of chronic bacterial prostatitis due to Chlamydia trachomatis infection:Results from a prospective,randomized and open-label study.Methods Find Exp Clin Pharmacol,2010,32(1):39-45.
[92] Skerk V,Schonwald S,Krhen I,et al.Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis.Int J Antimicrob Agents,2003,21(5):457-462.
[93] Mehik A,Alas P,Nickel JC,et al.Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome:A prospective,randomized,double-blind,placebo-controlled,pilot study.Urology,2003,62(3):425-429.
[94] 李昕,李宁忱,丁强,等.α1肾上腺素能受体阻滞剂萘哌地尔治疗慢性非细菌性前列腺炎的临床研究.中华男科学杂志,2006,12(3):234-236.
[95] Anothaisintawee T,Attia J,Nickel JC,et al.Management of chronic prostatitis/chronic pelvic pain syndrome:A systematic review and network meta-analysis.JAMA,2011,305(1):78-86.
[96] Yokoyama T,Hara R,Fukumoto K,et al.Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia.Int J Urol,2011,18(3):225-230.
[97] Zhao WP,Zhang ZG,Li XD,et al.Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA).Braz J Med Biol Res,2009,42(10):963-967.
[98] 曾晓勇,叶章群,杨为民,等.塞来昔布治疗ⅢA型前列腺炎的临床评估.中华男科学,2004,10(4):278-281.
[99] Nickel JC,Pontari MA,Moon T,et al.A randomized,placebo controlled,multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis.J Urol,2003,169(4):1401-1405.
[100] 邓春华,丘少鹏,梁宏,等.帕罗西汀佐治慢性前列腺炎63例.新医学,2000,31(10):599.
[101] 乔博义.氟西汀协同治疗伴情绪障碍的慢性前列腺炎.中华男科学,2004,10(2):145-146.
[102] Xia D,Wang P,Chen J,et al.Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.Chin Med J (Engl),2011,124(14):2158-2161.
[103] Shoskes DA,Nickel JC,Kattan MW.Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome:A prospective study using UPOINT.Urology,2010,75(6):1249-1253.
[104] Takahashi S,Kato D,Tabuchi H,et al.Safety and effectiveness of mirabegron in male patients with overactive bladder with or without benign prostatic hyperplasia:A Japanese post-marketing study.Low Urin Tract Symptoms,2020,13(1):79-87.
[105] Nickel JC,Downey J,Pontari MA,et al.A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).BJU Int,2004,93(7):991-995.
[106] Leskinen M,Lukkarinen O,Marttila T.Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome:A double-blind,placebo-controlled,pilot study.Urology,1999,53(3):502-505.
[107] Aboumarzouk OM,Nelson RL.Pregabalin for chronic prostatitis.Cochrane Database Syst Rev,2012,(8):D9063.
[108] Zhang K,Guo RQ,Chen SW,et al.The efficacy and safety of Serenoa repens extract for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome:A multicenter,randomized,double-blind,placebo-controlled trial.World J Urol,2021,39(9):3489-3495.
[109] 王传航,李兰群,周强,等.普乐安片治疗慢性前列腺炎多中心临床观察.中国现代应用药学,2010,27(11):1054-1056.
[110] 宁克勤,吉庆.慢性盆腔疼痛综合征中医辨治要略.江苏中医药,2010,42(9):57-58.
[111] 彭亚杰,张云山,樊立鹏,等.从“湿热、毒、瘀”浅谈慢性盆腔疼痛综合征的病因病机.环球中医药,2020,13(2):302-304.
[112] 李海松,王彬,赵冰.慢性前列腺炎中医诊治专家共识.北京中医药,2015,34(5):412-415.
[113] 商学军,耿强,段建敏,等.龙金通淋胶囊治疗Ⅲ型前列腺炎的疗效与安全性研究.中华男科学杂志,2014,20(12):1109-1112.
[114] 宁泌泰胶囊临床应用中国专家共识编写组.宁泌泰胶囊在慢性前列腺炎中临床应用中国专家共识.中华男科学杂志,24(5):462-465.
[115] 金珊,何锦华,姜华,等.尿清舒颗粒治疗慢性非细菌性前列腺炎(湿热下注证)的有效性与安全性.中国医院药学杂志,2017,37(19):1969-1973,1978.
[116] 万军,包奇昌,傅斌,等.血尿安胶囊联合左氧氟沙星治疗慢性细菌性前列腺炎的疗效观察.中草药,2020,51(23):6050-6053.
[117] 中国中医药信息学会男科分会.前列舒通胶囊在慢性前列腺炎中临床应用中国专家共识.中华男科学杂志,2018,24(12):1142-1145.
[118] 李海松.慢性前列腺炎中西医融合药物治疗专家共识.中国男科学杂志,2021,35(4):55-58.
[119] 前列倍喜胶囊在慢性前列腺炎中临床应用中国专家共识编写组.前列倍喜胶囊在慢性前列腺炎中临床应用中国专家共识.中华男科学杂志,2021,27(4):366-369.
[120] 王福,虞永江,白强.清浊祛毒丸在慢性前列腺炎中临床应用中国专家共识.中华男科学杂志,2019,25(12):1135-1138.
[121] 管斯琪,王彬.双石通淋胶囊治疗慢性前列腺炎临床应用专家共识.中华男科学杂志,2020,26(10):949-952.
[122] 李海松,王彬,卫元璋,等.前列欣胶囊对慢性非细菌性前列腺炎(气滞血瘀证)疼痛的影响.中国男科学杂志,2010,24(12):47-48.
[123] 邵耀宁,梁宝坚,廖光辉.少腹逐瘀汤治疗寒凝血瘀型慢性前列腺炎临床研究.新中医,2019,51(9):68-70.
[124] 叶轻衣,袁从容.知柏地黄丸联合阿奇霉素治疗慢性前列腺炎随机平行对照研究.实用中医内科杂志,2013,27(2):20-21.
[125] 黄建波,陈明显,周本初,等.补中益气汤加味治疗慢性前列腺炎的理论探讨.中华中医药杂志,2014,29(6):2007-2009.
[126] 郭俊,晏斌,高庆和,等.前列安栓治疗慢性前列腺炎有效性与安全性的Meta分析.中医学报,2021,36(8):1789-1794.
[127] Liu BP,Wang YT,Chen SD.Effect of acupuncture on clinical symptoms and laboratory indicators for chronic prostatitis/chronic pelvic pain syndrome:A systematic review and meta-analysis.Int Urol Nephrol,2016,48(12):1977-1991.
[128] 刘绍明,息金波,陈小均,等.芎柏前列散穴位贴敷治疗Ⅲ型前列腺炎综合征临床观察.中国针灸,2012,32(3):201-204.
[129] 杨忠圣,祖雄兵,齐琳,等.生物反馈和电刺激联合治疗慢性前列腺炎/慢性骨盆疼痛综合征.中华男科学杂志,2011,17(7):611-614.
[130] Wang J,Qi L,Zhang XY,et al.Consolidation therapy is necessary following successful biofeedback treatment for pubertal chronic prostatitis patients:A 3-year follow-up study.J Int Med Res,2013,41(2):410-417.
[131] Wilson JM,Loenneke JP,Jo E,et al.The effects of endurance,strength,and power training on muscle fiber type shifting.J Strength Cond Res,2012,26(6):1724-1729.
[132] Zhou MJ,Yang MY,Chen L,et al.The effectiveness of long-needle acupuncture at acupoints BL30 and BL35 for CP/CPPS:A randomized controlled pilot study.BMC Complement Altern Med,2017,17(1):263.
[133] Kim TH,Han DH,Cho WJ,et al.The efficacy of extracorporeal magnetic stimulation for treatment of chronic prostatitis/chronic pelvic pain syndrome patients who do not respond to pharmacotherapy.Urology,2013,82(4):894-898.
[134] Rowe E,Smith C,Laverick L,et al.A prospective,randomized,placebo controlled,double-blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of followup.J Urol,2005,173(6):2044-2047.
[135] 何伟,孙自学,王光策.磁振磁电治疗仪联合前列倍喜胶囊治疗慢性前列腺炎/慢性骨盆疼痛综合征的临床疗效观察.中华男科学杂志,2020,26(5):452-456.
[136] Jin JX,Wang HZ,Zhai ZX,et al.Transrectal microwave thermotherapy causing a short-time influence on sperm quality in Chinese chronic nonbacterial prostatitis patients.Asian J Androl,2017,19(5):548-553.
[137] Mykoniatis I,Kalyvianakis D,Zilotis F,et al.Evaluation of a low-intensity shockwave therapy for chronic prostatitis type IIIb/chronic pelvic pain syndrome:A double-blind randomized sham-controlled clinical trial.Prostate Cancer Prostatic Dis,2021,24(2):370-390.
[138] Guu SJ,Liu CC,Juan YS,et al.The 12-month follow-up of the low-intensity extracorporeal shockwave therapy in the treatment of patients with chronic pelvic pain syndrome refractory to 3-As medications.Aging Male,2019,23(5):793-800.
[139] Mykoniatis I,Pyrgidis N,Sokolakis I,et al.Low-intensity shockwave therapy for the management of chronic prostatitis/chronic pelvic pain syndrome:A systematic review and meta-analysis.BJU Int,2021,128(2):144-152.
[140] Lin G,Amanda RM,Lin M,et al.Effects and mechanisms of low-intensity pulsed ultrasound for chronic prostatitis and chronic pelvic pain syndrome.Int J Mol Sci,2016,17(7):1057.
[141] Jin C,Zhang S,Mo F,et al.Efficacy and safety evaluation of low-intensity extracorporeal shock wave therapy on prostatitis-like symptoms:An open-label,single-arm trial.Andrologia,2022,54(1):e14260.
[142] Nickel JC,Mullins C,Tripp DA.Development of an evidence-based cognitive behavioral treatment program for men with chronic prostatitis/chronic pelvic pain syndrome.World J Urol,2008,26(2):167-172.
[143] Wang J,Liang K,Sun H,et al.Psychotherapy combined with drug therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome:A randomized controlled trial.Int J Urol,2018,25(8):710-715.
[144] Tripp DA,Nickel JC,Katz L.A feasibility trial of a cognitive-behavioural symptom management program for chronic pelvic pain for men with refractory chronic prostatitis/chronic pelvic pain syndrome.Can Urol Assoc J,2011,5(5):328-332.
[145] Li HJ,Kang DY.Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome:A meta-analysis.World J Urol,2016,34(7):1009-1017.
[146] Mo MQ,Long LL,Xie WL,et al.Sexual dysfunctions and psychological disorders associated with type IIIa chronic prostatitis:A clinical survey in China.Int Urol Nephrol,2014,46(12):2255-2261.
[147] Shoskes DA,Berger R,Elmi A,et al.Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome:The chronic prostatitis cohort study.J Urol,2008,179(2):556-560.
[148] Dimitrakov J,Joffe HV,Soldin SJ,et al.Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome.Urology,2008,71(2):261-266.
[149] Zhao Z,Xuan X,Zhang J,et al.A prospective study on association of prostatic calcifications with sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).J Sex Med,2014,11(10):2528-2536.
[150] Giannantoni A,Porena M,Gubbiotti M,et al.The efficacy and safety of duloxetine in a multidrug regimen for chronic prostatitis/chronic pelvic pain syndrome.Urology,2014,83(2):400-405.
[151] Zhang M,Li H,Ji Z,et al.Clinical study of duloxetine hydrochloride combined with doxazosin for the treatment of pain disorder in chronic prostatitis/chronic pelvic pain syndrome:An observational study.Medicine (Baltimore),2017,96(10):e6243.
[152] Cantoro U,Catanzariti F,Lacetera V,et al.Comparison of tamsulosin vs tamsulosin/sildenafil effectiveness in the treatment of erectile dysfunction in patients affected by type III chronic prostatitis.Arch Ital Urol Androl,2013,85(3):109-112.
[153] Anderson RU,Wise D,Sawyer T,et al.Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome:Improvement after trigger point release and paradoxical relaxation training.J Urol,2006,176(4):1534-1537.
[154] Gacci M,Corona G,Salvi M,et al.A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.Eur Urol,2012,61(5):994-1003.
[155] Ma C,Zhang J,Cai Z,et al.To evaluate the efficacy and safety of different kinds of PDE5-Is with tamsulosin as a medical therapy for LUTS secondary to benign prostatic hyperplasia:A protocol for systematic review and meta analysis.Medicine (Baltimore),2020,99(3):e18712.
[156] Sebastianelli A,Spatafora P,Morselli S,et al.Tadalafil alone or in combination with tamsulosin for the management for LUTS/BPH and ED.Curr Urol Rep,2020,21(12):56.
[157] Liang CZ,Zhang XJ,Hao ZY,et al.Prevalence of sexual dysfunction in Chinese men with chronic prostatitis.BJU Int,2004,93(4):568-570.
[158] Lee JH,Lee SW.Relationship between premature ejaculation and chronic prostatitis/chronic pelvic pain syndrome.J Sex Med,2015,12(3):697-704.
[159] Liang CZ,Hao ZY,Li HJ,et al.Prevalence of premature ejaculation and its correlation with chronic prostatitis in Chinese men.Urology,2010,76(4):962-966.
[160] Li XC,Zhang XB,Liao ZC,et al.Is mild erectile dysfunction associated with severe psychological symptoms in Chinese patients with moderate-to-severe chronic prostatitis/chronic pelvic pain syndrome?Asian J Androl,2020,23(3):319-324.
[161] Mcmahon CG,Jannini EA,Serefoglu EC,et al.The pathophysiology of acquired premature ejaculation.Transl Androl Urol,2016,5(4):434-449.
[162] Salonia A,Bettocchi C,Boeri L,et al.European Association of Urology Guidelines on Sexual and Reproductive Health-2021 Update:Male sexual dysfunction.Eur Urol,2021,80(3):333-357.
[163] Salonia A,Bettocchi C,Carvalho J,et al.EAU guidelines on sexual and reproductive health.Eur Ass Urol,2022,292.
[164] El-Nashaar A,Shamloul R.Antibiotic treatment can delay ejaculation in patients with premature ejaculation and chronic bacterial prostatitis.J Sex Med,2007,4(2):491-496.
[165] Zohdy W.Clinical parameters that predict successful outcome in men with premature ejaculation and inflammatory prostatitis.J Sex Med,2009,6(11):3139-3146.
[166] Shamloul R,El-Nashaar A.Chronic prostatitis in premature ejaculation:A cohort study in 153 men.J Sex Med,2006,3(1):150-154.
[167] Cai T,Pisano F,Magri V,et al.Chlamydia trachomatis infection is related to premature ejaculation in chronic prostatitis patients:Results from a cross-sectional study.J Sex Med,2014,11(12):3085-3092.
[168] Yang J,Zhang QJ,Zhang JY,et al.Upregulated expression of NMDA receptor in the paraventricular nucleus shortens ejaculation latency in rats with experimental autoimmune prostatitis.Andrology,2021,9(1):352-360.
[169] Nickel JC,Elhilali M,Emberton M,et al.The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS),quality of life and sexual dysfunction in men with LUTS and painful ejaculation.BJU Int,2006,97(6):1242-1246.
[170] Zhao L,Tian R,Liang C,et al.Beneficial effect of tamsulosin combined with dapoxetine in management of type III prostatitis with premature ejaculation.Andrologia,2019,51(8):e13319.
[171] Schoor RA.Prostatitis and male infertility:Evidence and links.Curr Urol Rep,2002,3(4):324-329.
[172] 李宏军,许蓬,刘军生,等.男性不育患者慢性前列腺炎的发病调查及其对生育的影响.中华医学杂志,2004,84(5):21-23.
[173] Schaeffer AJ.Clinical practice.Chronic prostatitis and the chronic pelvic pain syndrome.N Engl J Med,2006,355(16):1690-1698.
[174] Ihsan AU,Khan FU,Khalil P,et al.Role of oxidative stress in pathology of chronic prostatitis/chronic pelvic pain syndrome and male infertility and antioxidants function in ameliorating oxidative stress.Biomed Pharmacother,2018,106:714-723.
[175] Hu Y,Niu X,Wang G,et al.Chronic prostatitis/chronic pelvic pain syndrome impairs erectile function through increased endothelial dysfunction,oxidative stress,apoptosis,and corporal fibrosis in a rat model.Andrology,2016,4(6):1209-1216.
[176] Rivero VE,Motrich RD,Maccioni M,et al.Autoimmune etiology in chronic prostatitis syndrome:An advance in the understanding of this pathology.Crit Rev Immunol,2007,27(1):33-46.
[177] Lampiao F,du Plessis SS.TNF-alpha and IL-6 affect human sperm function by elevating nitric oxide production.Reprod Biomed Online,2008,17(5):628-631.
[178] Bisht S,Faiq M,Tolahunase M,et al.Oxidative stress and male infertility.Nat Rev Urol,2017,14(8):470-485.
[179] Jiang Y,Cui D,Du Y,et al.Association of anti-sperm antibodies with chronic prostatitis:A systematic review and meta-analysis.J Reprod Immunol,2016,118(11):85-91.
[180] Condorelli RA,Russo GI,Calogero AE,et al.Chronic prostatitis and its detrimental impact on sperm parameters:A systematic review and meta-analysis.J Endocrinol Invest,2017,40(11):1209-1218.
[181] Alshahrani S,Mcgill J,Agarwal A.Prostatitis and male infertility.J Reprod Immunol,2013,100(1):30-36.
[182] Zhao J,Dong X,Hu X,et al.Zinc levels in seminal plasma and their correlation with male infertility:A systematic review and meta-analysis.Sci Rep,2016,6(3):22386.
[183] Schagdarsurengin U,Teuchert LM,Hagenk?tter C,et al.Chronic prostatitis affects male reproductive health and is associated with systemic and local epigenetic inactivation of C-X-C motif chemokine 12 receptor C-X-C chemokine receptor type 4.Urol Int,2017,98(1):89-101.
[184] Henkel R,Ludwig M,Schuppe H,et al.Chronic pelvic pain syndrome/chronic prostatitis affect the acrosome reaction in human spermatozoa.World J Urol,2006,24(1):39-44.
[185] Schagdarsurengin U,Western P,Steger K,et al.Developmental origins of male subfertility:Role of infection,inflammation,and environmental factors.Semin Immunopathol,2016,38(6):765-781.
[186] Jungwirth A,Diemer T,Kopa Z,et al.EAU Guidelines on Male Infertility.Eurn Ass Urol,2019,24-26.
[187] Bj?rn R,Christian AB,Sascha A,et al.Assessing psychological factors,social aspects and psychiatric co-morbidity associated with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in men - A systematic review.J Psychosom Res,2014,77(5):333-350.
[188] Huang X,Qin Z,Cui H,et al.Psychological factors and pain catastrophizing in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS):A meta-analysis.Transl Androl Urol,2020,9(2):485-493.
[189] 张凯,贺利军,虞巍,等.22 ~ 50 岁中国人精神心理健康状况与下尿路症状及阴茎勃起功能障碍的相关性(英文).北京大学学报(医学版),2013,45(4):609-612.
[190] Brünahl CA,Klotz SGR,Dybowski C,et al.Physiotherapy and combined cognitive-behavioural therapy for patients with chronic pelvic pain syndrome:Results of a non-randomised controlled feasibility trial.BMJ Open,2021,11(12):e53421.
[191] Hu C,Yang H,Zhao Y,et al.The role of inflammatory cytokines and ERK1/2 signaling in chronic prostatitis/chronic pelvic pain syndrome with related mental health disorders.Sci Rep,2016,6(1):28608.
[192] Watanabe T,Inoue M,Sasaki K,et al.Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment.BJU Int,2011,108(2):248-251.
[193] Korkmaz S,Karadag MA,Hamamcioglu K,et al.Electrophysiological identification of central sensitization in patients with chronic prostatitis.Urol J,2015,12(4):2280-2284.
[194] Nickel JC,Roehrborn CG,O'Leary MP,et al.The relationship between prostate inflammation and lower urinary tract symptoms:Examination of baseline data from the REDUCE trial.Eur Urol,2008,54(6):1379-1384.
[195] 郑少波,刘春晓,徐亚文,等.经尿道电切治疗合并前列腺炎的小体积前列腺增生.中华男科学杂志,2011,17(8):755-757.
[196] 董建胜,邱建国.TUVP联合术前后用药治疗良性前列腺增生症合并慢性前列腺炎的临床疗效观察.国际泌尿系统杂志,2013,33(6):766-769.
[197] 邹如政,曹继刚,李亚昊,等.慢性非细菌性前列腺炎/慢性盆底疼痛综合征中医药治疗的近况.中国男科学杂志,2015,29(11):69-72.
[198] Meyers J.Exercise is effective therapy for chronic nonbacterial prostatitis and chronic pelvic pain syndrome.Am Fam Physician,2016,94(7):533.
[199] Gianluca G,Nicola M,Andrea M,et al.Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments — could it represent a valid option?The physical activity and male pelvic pain trial:A double-blind,randomized study.J Urol,2007,177(1):159-165.
[200] Xu Y,Zhang L,Shen Y,et al.Effectiveness of psychological interventions for treating chronic prostatitis/chronic pelvic pain syndrome:A protocol for systematic review and meta-analysis.Medicine,2020,99(39):e22151.
[201] Cohen JM,Fagin AP,Hariton E,et al.Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS):A systematic review and meta-analysis.PLoS One,2012,7(8):e41941.
基本信息:
DOI:10.13263/j.cnki.nja.2022.06.012
中图分类号:R697.33
引用信息:
[1].慢性前列腺炎/慢性盆腔疼痛综合征诊疗指南[J].中华男科学杂志,2022,28(06):544-559.DOI:10.13263/j.cnki.nja.2022.06.012.
2022-06-20
2022-06-20